Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 101

Similar articles for PubMed (Select 16736286)

1.

Determinants of preferences for genetic counselling in Jewish women.

Apicella C, Peacock SJ, Andrews L, Tucker K, Bankier A, Daly MB, Hopper JL.

Fam Cancer. 2006;5(2):159-67.

PMID:
16736286
2.

A discrete choice experiment of preferences for genetic counselling among Jewish women seeking cancer genetics services.

Peacock S, Apicella C, Andrews L, Tucker K, Bankier A, Daly MB, Hopper JL.

Br J Cancer. 2006 Nov 20;95(10):1448-53.

3.

Satisfaction with genetic counseling for BRCA1 and BRCA2 mutations among African American women.

Charles S, Kessler L, Stopfer JE, Domchek S, Halbert CH.

Patient Educ Couns. 2006 Oct;63(1-2):196-204. Epub 2006 Mar 14.

PMID:
16533589
4.

Referral and experience with genetic testing among women with early onset breast cancer.

Brown KL, Hutchison R, Zinberg RE, McGovern MM.

Genet Test. 2005 Winter;9(4):301-5.

PMID:
16379543
5.

Genetic counseling and testing for breast-ovarian cancer susceptibility: what do women want?

Audrain J, Rimer B, Cella D, Garber J, Peshkin BN, Ellis J, Schildkraut J, Stefanek M, Vogel V, Lerman C.

J Clin Oncol. 1998 Jan;16(1):133-8.

PMID:
9440734
6.

Development and pilot testing of a decision aid for men considering genetic testing for breast and/or ovarian cancer-related mutations (BRCA1/2).

Juan AS, Wakefield CE, Kasparian NA, Kirk J, Tyler J, Tucker K.

Genet Test. 2008 Dec;12(4):523-32. doi: 10.1089/gte.2008.0035.

PMID:
19072564
7.

Direct-to-patient BRCA1 testing: the Twoj Styl experience.

Gronwald J, Huzarski T, Byrski T, Debniak T, Metcalfe K, Narod SA, Lubiński J.

Breast Cancer Res Treat. 2006 Dec;100(3):239-45. Epub 2006 Jun 29.

PMID:
16807675
8.

Cancer risks for Australian women with a BRCA1 or a BRCA2 mutation.

Suthers GK.

ANZ J Surg. 2007 May;77(5):314-9.

PMID:
17497966
9.

Subjective and objective risk of ovarian cancer in Ashkenazi Jewish women testing for BRCA1/2 mutations.

Kelly KM, Senter L, Leventhal H, Ozakinci G, Porter K.

Patient Educ Couns. 2008 Jan;70(1):135-42. Epub 2007 Nov 7.

PMID:
17988821
10.

Genetic testing for BRCA1: effects of a randomised study of knowledge provision on interest in testing and long term test uptake; implications for the NICE guidelines.

Hall J, Gray S, A'Hern R, Shanley S, Watson M, Kash K, Croyle R, Eeles R.

Fam Cancer. 2009;8(1):5-13. doi: 10.1007/s10689-008-9201-0. Epub 2008 Aug 5.

PMID:
18679829
11.

Decision making regarding prophylactic mastectomy: stability of preferences and the impact of anticipated feelings of regret.

van Dijk S, van Roosmalen MS, Otten W, Stalmeier PF.

J Clin Oncol. 2008 May 10;26(14):2358-63. doi: 10.1200/JCO.2006.10.5494.

12.
13.

Evaluation of BRCA1 and BRCA2 mutations and risk-prediction models in a typical Asian country (Malaysia) with a relatively low incidence of breast cancer.

Thirthagiri E, Lee SY, Kang P, Lee DS, Toh GT, Selamat S, Yoon SY, Taib NA, Thong MK, Yip CH, Teo SH.

Breast Cancer Res. 2008;10(4):R59. doi: 10.1186/bcr2118. Epub 2008 Jul 16.

14.

Disparities in BRCA testing: when insurance coverage is not a barrier.

Olaya W, Esquivel P, Wong JH, Morgan JW, Freeberg A, Roy-Chowdhury S, Lum SS.

Am J Surg. 2009 Oct;198(4):562-5. doi: 10.1016/j.amjsurg.2009.07.003.

PMID:
19800469
15.

BRCA1 and BRCA2 genetic testing in Italian breast and/or ovarian cancer families: mutation spectrum and prevalence and analysis of mutation prediction models.

Capalbo C, Ricevuto E, Vestri A, Ristori E, Sidoni T, Buffone O, Adamo B, Cortesi E, Marchetti P, Scambia G, Tomao S, Rinaldi C, Zani M, Ferraro S, Frati L, Screpanti I, Gulino A, Giannini G.

Ann Oncol. 2006 Jun;17 Suppl 7:vii34-40.

16.

[BRCA1 and BRCA2 mutations in families studied in the program of genetic counselling in cancer of the Valencian community (Spain)].

Esteban Cardeñosa E, Bolufer Gilabert P, Palanca Suela S, Barragán González E, Oltra Soler S, Chirivella González I, Segura Huerta A, Guillén Ponce C, Martínez de Dueñas E, Cuevas Cuerda D, Salas Trejo D; Grupo de Asesoramiento en Cáncer Hereditario de la Comunidad Valenciana.

Med Clin (Barc). 2008 Feb 9;130(4):121-6. Spanish.

PMID:
18279628
17.

Recall of and reactions to a surgeon referral letter for BRCA genetic counseling among high-risk breast cancer patients.

Vadaparampil ST, Quinn GP, Miree CA, Brzosowicz J, Carter B, Laronga C.

Ann Surg Oncol. 2009 Jul;16(7):1973-81. doi: 10.1245/s10434-009-0479-4. Epub 2009 Apr 30.

PMID:
19408048
18.

Concomitant BRCA1 and BRCA2 gene mutations in an Ashkenazi Jewish woman with primary breast and ovarian cancer.

Spannuth WA, Thaker PH, Sood AK.

Am J Obstet Gynecol. 2007 Apr;196(4):e6-9.

PMID:
17403394
19.

Experiences of genetic counseling for BRCA1/2 among recently diagnosed breast cancer patients: a qualitative inquiry.

Vadaparampil ST, Quinn GP, Brzosowicz J, Miree CA.

J Psychosoc Oncol. 2008;26(4):33-52.

PMID:
19042271
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk